Our Plan

MYRN was established with 4 principal goals in mind:

  1. To develop, support and undertake programmes of clinical population based and laboratory research aimed at reducing the burden of cardiovascular disease in high incidence countries.
  2. To contribute to the development of appropriate policy and practice for improved  cardiovascular health and outcomes, particularly across the Middle East and Africa.
  3. To invest in the development of a generation of world class researchers, clinicians and support personnel in the countries in which it operates.
  4. To contribute to the development of biotechnology in the cardiovascular field.